For instance, CYP1A2 expression levels can serve as a biomarker of HCC recurrence caused by hepatitis C [2], and CYP3A5 can act as a tumor suppressor gene by regulating the mTORC2/Akt signaling pathway in HCC [3]. The gene discussed is CYP3A5; the disease is hepatocellular carcinoma.